Co-Diagnostics, Inc. (CODX) stock

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30

$0.28−0.01 (-3.78%)

Close on Nov 11, 2026Market cap $1.74MP/E –Yield –

Co-Diagnostics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Co-Diagnostics's EV/EBITDA was 1.3× on Jan 31, 2023, against 3.3× a year earlier. Over the last 2 years it ranged from 0.4× to 34.7×, with a median of 3.3×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2023	Jan 31, 2023	1.3×	+0.7
2022	Nov 30, 2022	0.6×	−2.7
2021	Dec 31, 2021	3.3×	−6.4
2020	Dec 31, 2020	9.7×	–

Where these numbers come from

Parsed from the XBRL in Co-Diagnostics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Jan 2, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing